Liver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy AndImmunosuppressants) - Global ...
3.4.1.4 Increased Vaccination In Emerging Economies3.4.2 Liver Disease Therapeutics Market Drivers Impact Analysis3.4.3 Re...
4.3.4 Symptoms4.3.5 Pathophysiology4.3.6 Treatment Pattern And Therapy Options4.3.6.1 Chemotherapy4.3.6.2 Targeted Therapy...
4.5.4.2 Epidemiology4.5.4.3 Etiology4.5.4.4 Symptoms4.5.4.5 Pathophysiology4.5.4.6 Treatment Pattern And Therapy Options4....
6.1.8 Agreements And Collaborationschapter 7 Recommendations7.1 Market Strategy For Success7.2 Barriers To Be Consideredch...
8.5.1 Company Overview8.5.2 Financial Overview8.5.3 Business Strategies8.5.3.1 Research And Development Investments8.5.3.2...
8.10.3 Business Strategies8.10.3.1 Investing In Research And Development8.10.4 Product Portfolio8.10.5 Recent Developments...
USA - Canada Toll Free 866-997-4948Email: sales@researchmoz.usBlog: http://researchmoz.blogspot.com/Website: http://www.re...
Upcoming SlideShare
Loading in...5
×

Liver Diseases Therapeutics Market

145

Published on

This report also covers an in-depth competitive analysis for the market, taking into consideration some of the major market players. The market players considered are: Abbott Laboratories, Astellas Pharma Inc, Gilead Science Inc., Merck & Co., Bristol-Myers Squibb, Novartis, Pfizer and Roche. A detailed analysis of their business strategies, company overview, financial overview, product portfolio and recent developments is also provided in the report.

Published in: Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
145
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Transcript of "Liver Diseases Therapeutics Market"

  1. 1. Liver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy AndImmunosuppressants) - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018 This report covers the performance of the various drugs class segment used in liver disease therapeutics interms of their revenue. The global market for liver diseases therapeutics is classified into seven drug classsegments namely, anti-viral drugs, vaccines, immunosuppressants, immunoglobulins, targeted therapy,corticosteroids and chemotherapy with their estimated and forecasted market size from 2012 to 2018, alongwith their compound annual growth rate. This report also covers an in-depth competitive analysis for the market, taking into consideration some of themajor market players. The market players considered are: Abbott Laboratories, Astellas Pharma Inc, GileadScience Inc., Merck & Co., Bristol-Myers Squibb, Novartis, Pfizer and Roche. A detailed analysis of theirbusiness strategies, company overview, financial overview, product portfolio and recent developments is alsoprovided in the report. We have used secondary research for deriving our market numbers for each segment of the research reportand further validated our analysis with C-level executives of major companies operating in liver diseasestherapeutics market through the means of primary research to finally come up with our results. This research isspecially designed to estimate and analyze the performance of liver diseases therapeutics in a global scenario.This research provides in-depth analysis of liver diseases therapeutics market sales, trend analysis bysegments.table Of Contentchapter 1 Preface1.1 Report Description1.2 Research Methodologychapter 2 Executive Summarychapter 3 Market Overview3.1 Introduction3.2 Market Size3.3 Comparative Analysis Of Global Liver Diseases Therapeutics Market, By Drug Class, 2011 & 20183.4 Liver Diseases Therapeutics Market Dynamics3.4.1 Drivers3.4.1.1 Aging Population Inducing Chronic Liver Diseases Such As Hepatitis And Liver Cancer3.4.1.2 Increasing Global Prevalence Of Liver Diseases3.4.1.3 High Unmet Needs Exist In The Liver Cancer TherapeuticsLiver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy And Immunosuppressants) - Global Industry A
  2. 2. 3.4.1.4 Increased Vaccination In Emerging Economies3.4.2 Liver Disease Therapeutics Market Drivers Impact Analysis3.4.3 Restraints3.4.3.1 Side-effects And Risks3.4.3.2 Fda Approvals And Other Government Regulations3.4.3.3 Availability Of Alternate Treatment Procedures3.4.4 Liver Disease Therapeutics Market Restraints Impact Analysis3.4.5 Opportunities3.4.5.1 Strong Pipeline Drugs3.4.5.2 Emerging Economies In Asia, Latin America And Eastern European Countries3.4.5.3 Consolidation Opportunities In The Healthcare Industry3.5 Porter’s Five Forces Analysis For Liver Diseases Therapeutics Market3.5.1 Bargaining Power Of Suppliers3.5.2 Bargaining Power Of Buyers3.5.3 Threat Of New Entrants3.5.4 Threat Of Substitutes3.5.5 Competitive Rivalrychapter 4 Liver Diseases Classification And Therapy Options4.1 Alcohol Induced Liver Disease4.1.1 Overview4.1.2 Epidemiology4.1.3 Etiology4.1.4 Symptoms4.1.5 Pathophysiology4.1.6 Treatment Pattern And Therapy Options4.1.6.1 Anabolic Steroids4.1.6.2 Alcohol Abuse Drugs4.2 Autoimmune Liver Disorder4.2.1 Autoimmune Hepatitis (aih)4.2.1.1 Overview4.2.1.2 Epidemiology4.2.1.3 Etiology4.2.1.4 Symptoms4.2.1.5 Pathophysiology4.2.1.6 Treatment Pattern And Therapy Options4.2.1.6.1 Antimetabolites4.2.1.6.2 Corticosteroids4.3 Hepatocellular Carcinoma4.3.1 Overview4.3.2 Epidemiology4.3.3 EtiologyLiver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy And Immunosuppressants) - Global Industry A
  3. 3. 4.3.4 Symptoms4.3.5 Pathophysiology4.3.6 Treatment Pattern And Therapy Options4.3.6.1 Chemotherapy4.3.6.2 Targeted Therapy4.4 Non-alcoholic Fatty Liver Disease4.4.1 Overview4.4.2 Epidemiology4.4.3 Etiology4.4.4 Symptoms4.4.5 Pathophysiology4.4.6 Treatment Pattern And Therapy Options4.4.6.1 Gallstone Solubilising Drugs4.5 Viral/hepatitis Liver Disorder4.5.1 Hepatitis A4.5.1.1 Overview4.5.1.2 Epidemiology4.5.1.3 Etiology4.5.1.4 Symptoms4.5.1.5 Pathophysiology4.5.1.6 Treatment Pattern And Therapy Options4.5.1.6.1 Vaccines4.5.1.6.2 Immunoglobulins4.5.2 Hepatitis B4.5.2.1 Overview4.5.2.2 Epidemiology4.5.2.3 Etiology4.5.2.4 Symptoms4.5.2.5 Pathophysiology4.5.2.6 Treatment Pattern And Therapy Options4.5.2.6.1 Antiviral Drugs4.5.2.6.2 Immunoglobulins4.5.2.6.3 Vaccines4.5.3 Hepatitis C4.5.3.1 Overview4.5.3.2 Epidemiology4.5.3.3 Etiology4.5.3.4 Symptoms4.5.3.5 Pathophysiology4.5.3.6 Treatment Pattern And Therapy Options4.5.3.6.1 Antiviral Drugs4.5.4 Hepatitis D4.5.4.1 OverviewLiver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy And Immunosuppressants) - Global Industry A
  4. 4. 4.5.4.2 Epidemiology4.5.4.3 Etiology4.5.4.4 Symptoms4.5.4.5 Pathophysiology4.5.4.6 Treatment Pattern And Therapy Options4.5.5 Hepatitis E4.5.5.1 Overview4.5.5.2 Epidemiology4.5.5.3 Etiology4.5.5.4 Symptoms4.5.5.5 Pathophysiology4.5.5.6 Treatment Pattern And Therapy Optionschapter 5 Liver Diseases Therapeutics Market, By Drug Class5.1 Immunosuppressants5.1.1 Global immunosuppressants Market For Liver Disease Therapeutics, 2010 – 2018 (usd Million)5.2 Chemotherapy Drugs5.2.1 Global Chemotherapy Drugs Market For Liver Disease Therapeutics, 2010 – 2018 (usd Million)5.3 Targeted Therapy Drugs5.3.1 Global Targeted Therapy Market For Liver Disease Therapeutics, 2010 – 2018 (usd Million)5.4 Vaccines5.4.1 Global Vaccines Market For Liver Disease Therapeutics, 2010 – 2018 (usd Million)5.5 Anti-viral Drugs5.5.1 Global Anti-viral Drugs Market For Liver Disease Therapeutics, 2010 – 2018 (usd Million)5.6 Immunoglobulins5.6.1 Global Immunoglobulins Market For Liver Disease Therapeutics, 2010 – 2018 (usd Million)5.7 Corticosteriods5.7.1 Global Corticosteriods Market For Liver Disease Therapeutics, 2010 – 2018 (usd Million)chapter 6 Competitive Landscape6.1 Market Share Of Key Players In Liver Diseases Therapeutics Market By Drug Class6.1.1 Market Share Of Key Players For immunosuppressants Market For Liver Diseases6.1.2 Market Share Of Key Players For Vaccines Market For Liver Diseases6.1.3 Market Share Of Key Players For Anti-viral Drugs Market For Liver Diseases6.1.4 Market Share Of Key Players For Targeted Therapy For Liver Diseases6.1.5 New Entrants (phase Iii)6.1.6 Competitive Strategy By Key Players6.1.6.1 Investments In R&d And Clinical Studies6.1.6.2 Entering The Emerging Economies6.1.6.3 Investing In Different Segments Of The Market6.1.7 Competitive Strategy By New EntrantsLiver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy And Immunosuppressants) - Global Industry A
  5. 5. 6.1.8 Agreements And Collaborationschapter 7 Recommendations7.1 Market Strategy For Success7.2 Barriers To Be Consideredchapter 8 Company Profiles8.1 Abbott Laboratories8.1.1 Company Overview8.1.2 Financial Overview8.1.3 Business Strategies8.1.3.1 Significant R&d Investments For New Products Development8.1.3.2 Investing In Emerging Markets8.1.3.3 Conducting Clinical Trials8.1.4 Product Portfolio8.1.5 Recent Developments8.2 Astellas Pharma Inc.8.2.1 Company Overview8.2.2 Financial Overview8.2.3 Business Strategies8.2.3.1 Investing In Emerging Economies8.2.3.2 Investing In Research And Development8.2.4 Product Portfolio8.2.5 Recent Developments8.3 Bristol-myers Squibb8.3.1 Company Overview8.3.2 Financial Overview8.3.3 Business Strategies8.3.3.1 Mergers, Acquisitiosn And Strategic Development8.3.3.2 Investing In Research And Development8.3.4 Product Portfolio8.3.5 Recent Developments8.4 Gilead Sciences8.4.1 Company Overview8.4.2 Financial Overview8.4.3 Business Strategies8.4.3.1 Innovative New Products8.4.3.2 Investing In Research And Development8.4.4 Product Portfolio8.4.5 Recent Developments8.5 Glaxosmithkline PlcLiver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy And Immunosuppressants) - Global Industry A
  6. 6. 8.5.1 Company Overview8.5.2 Financial Overview8.5.3 Business Strategies8.5.3.1 Research And Development Investments8.5.3.2 Delivering New Products8.5.4 Product Portfolio8.5.5 Recent Developments8.6 F. Hoffmann-la Roche Ltd8.6.1 Company Overview8.6.2 Financial Overview8.6.3 Business Strategies8.6.3.1 Strategic Alliance Initiative8.6.3.2 Investing In Research And Development8.6.4 Product Portfolio8.6.5 Recent Developments8.7 Merck & Co. Inc8.7.1 Company Overview8.7.2 Financial Overview8.7.3 Business Strategies8.7.3.1 R&d Initiatives8.7.3.2 Strategic Alliance8.7.3.3 Corporate Social Responsibility And Awareness8.7.4 Product Portfolio8.7.5 Recent Developments8.8 Novartis Ag8.8.1 Company Overview8.8.2 Financial Overview8.8.3 Business Strategies8.8.3.1 Strategic Alliance8.8.3.2 Investing In Research And Development8.8.4 Product Portfolio8.8.5 Recent Developments8.9 Sanofi S.a8.9.1 Company Overview8.9.2 Financial Overview8.9.3 Business Strategies8.9.3.1 Business Diversification8.9.3.2 Research And Development Initiative8.9.4 Product Portfolio8.9.5 Recent Developments8.10 Pfizer Inc.8.10.1 Company Overview8.10.2 Financial OverviewLiver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy And Immunosuppressants) - Global Industry A
  7. 7. 8.10.3 Business Strategies8.10.3.1 Investing In Research And Development8.10.4 Product Portfolio8.10.5 Recent Developments8.11 Takeda Pharmaceutical8.11.1 Company Overview8.11.2 Financial Overview8.11.3 Business Strategies8.11.3.1 Investing In Emerging Economies8.11.3.2 Investing In Research And Development8.11.4 Product Portfolio8.11.5 Recent Developments8.12 Valeant Pharmaceuticals8.12.1 Company Overview8.12.2 Financial Overview8.12.3 Business Strategies8.12.3.1 Strategic Alliance8.12.4 Product Portfolio8.12.5 Recent Developments8.13 Watson Pharmaceuticals, Inc.8.13.1 Company Overview8.13.2 Financial Overview8.13.3 Business Strategies8.13.3.1 Investing In Generic And Biosimilar Segments8.13.3.2 Investing In Research And Development8.13.4 Product Portfolio8.13.5 Recent DevelopmentsAbout Us:Transparency Market Research is a market intelligence company providing global business informationreports and services. Our exclusive blend of quantitative forecasting and trends analysis providesforward-looking insight for thousands of decision makers. We are privileged with highly experienced team ofAnalysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques togather, and analyze information. Our business offerings represent the latest and the most reliable informationindispensable for businesses to sustain a competitive edge.Contact:ResearchMoz90 State Street,Suite 700,Albany NY - 12207United StatesTel: +1-518-618-1030Liver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy And Immunosuppressants) - Global Industry A
  8. 8. USA - Canada Toll Free 866-997-4948Email: sales@researchmoz.usBlog: http://researchmoz.blogspot.com/Website: http://www.researchmoz.us/Liver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy And Immunosuppressants) - Global Industry A

×